Jove
Visualize
Contact Us

Related Experiment Videos

Cephalosporins: rationale for clinical use.

A Molavi1

  • 1Division of Infectious Disease, Hahnemann University School of Medicine, Philadelphia, Pennsylvania.

American Family Physician
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1996
Same author

Infectious complications in the first 100 days after renal transplantation.

Transplantation proceedings·1995
Same author

Endocarditis: recognition, management, and prophylaxis.

Cardiovascular clinics·1993
Same author

Zidovudine for the treatment of HIV infection.

American family physician·1990
Same author

Pentamidine for the prevention and treatment of P. carinii pneumonia.

American family physician·1989
Same author

Clostridial endocarditis. Report of a case caused by Clostridium bifermentans and review of the literature.

Archives of internal medicine·1989
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Cephalosporins are key antibiotics, offering better resistance to beta-lactamases than penicillins. Their generation classification primarily reflects gram-negative activity, not gram-positive or anaerobic effectiveness.

Area of Science:

  • Pharmacology
  • Microbiology
  • Infectious Diseases

Background:

  • Cephalosporins are a widely used antibiotic class, valued for their beta-lactamase resistance.
  • Antibiotic resistance is a growing global health concern, necessitating understanding of drug efficacy.

Purpose of the Study:

  • To clarify the relationship between cephalosporin generations and their spectrum of activity against different bacterial types.
  • To highlight the specific strengths of each cephalosporin generation against Gram-negative, Gram-positive, and anaerobic bacteria.

Main Methods:

  • Review of existing literature on cephalosporin classification and antimicrobial activity.
  • Analysis of reported data on the efficacy of different cephalosporin generations against various bacterial pathogens.

Related Experiment Videos

Main Results:

  • Cephalosporin generations are primarily defined by their activity against Gram-negative bacteria.
  • First-generation cephalosporins show the highest activity against Gram-positive bacteria, including Staphylococcus aureus.
  • Third-generation cephalosporins exhibit excellent Gram-negative activity.
  • Cephamycins (a second-generation subgroup) demonstrate superior activity against anaerobic bacteria.

Conclusions:

  • The standard cephalosporin generation classification does not fully encompass their activity profiles against all bacterial types.
  • Understanding the specific spectrum of activity for each cephalosporin generation is crucial for effective antibiotic selection.
  • Cephamycins offer a valuable option for infections involving anaerobic organisms.